LZ Therapeutics develops therapeutics for patients at different stages of Parkinson’s disease. It offers neuroprotective/neurorestoritive therapies for early-stage Parkinson’s disease (PD); a combination therapy with levodopa-enhancing and anti-dyskinesia effects designed for mid-stage PD patients; and gene therapies for advanced PD patients. Lazarus will conduct pre-clinical testing of its drug in preparation for an Investigational New Drug filing

The Ben Franklin Technology Partners of Northeastern Pennsylvania has announced that the World Trade Club of the Lehigh Valley (WTCLV) has become an affiliate of Ben Franklin TechVentures. TechVentures is an award-winning technology incubator/post incubator facility owned and managed by Ben Franklin that is located on the campus of Lehigh University. The Continue Reading ...

Joseph Michelli, Ph.D., was keynote speaker at the Ben Franklin Technology Partners of Northeastern Pennsylvania’s 2010 i xchange, exploring the critical importance of creativity and innovation in delivering customer value and creating business opportunities. Michelli is an internationally sought-after speaker, author, and organizational consultant who has been described as Continue Reading ...